BridgeBio Pharma, Inc. 2.5% 15-MAR-2027BridgeBio Pharma, Inc. 2.5% 15-MAR-2027BridgeBio Pharma, Inc. 2.5% 15-MAR-2027

BridgeBio Pharma, Inc. 2.5% 15-MAR-2027

No trades
See on Supercharts

BBIO5151039 analysis



Key facts


Issue date
Mar 16, 2021
Maturity date
Mar 15, 2027
Outstanding amount
‪550.00 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
2.50% (Fixed)
Yield to maturity
1.34%
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.